192 related articles for article (PubMed ID: 19223666)
41. Nitrate tolerance: effect of thiol supplementation during prolonged nitroglycerin infusion in an in vivo rat model.
Boesgaard S; Petersen JS; Aldershvile J; Poulsen HE; Flachs H
J Pharmacol Exp Ther; 1991 Sep; 258(3):851-6. PubMed ID: 1909757
[TBL] [Abstract][Full Text] [Related]
42. Response of cultured cerebral artery smooth muscle cells to the nitric oxide vasodilators, nitroglycerin and sodium nitroprusside.
Tao H; Zhang LM; Castresana MR; Newman WH; Shillcutt SD
J Neurosurg Anesthesiol; 1997 Jan; 9(1):58-64. PubMed ID: 9016442
[TBL] [Abstract][Full Text] [Related]
43. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE.
Beer SM; Taylor ER; Brown SE; Dahm CC; Costa NJ; Runswick MJ; Murphy MP
J Biol Chem; 2004 Nov; 279(46):47939-51. PubMed ID: 15347644
[TBL] [Abstract][Full Text] [Related]
44. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
Henry PJ; Horowitz JD; Louis WJ
J Pharmacol Exp Ther; 1989 Feb; 248(2):762-8. PubMed ID: 2563771
[TBL] [Abstract][Full Text] [Related]
45. Acute effects of nitroglycerin depend on both plasma and intracellular sulfhydryl compound levels in vivo. Effect of agents with different sulfhydryl-modulating properties.
Boesgaard S; Poulsen HE; Aldershvile J; Loft S; Anderson ME; Meister A
Circulation; 1993 Feb; 87(2):547-53. PubMed ID: 8425299
[TBL] [Abstract][Full Text] [Related]
46. Biochemical and pharmacological interactions between nitroglycerin and thiols. Effects of thiol structure on nitric oxide generation and tolerance reversal.
Chong S; Fung HL
Biochem Pharmacol; 1991 Sep; 42(7):1433-9. PubMed ID: 1930267
[TBL] [Abstract][Full Text] [Related]
47. Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl-based redox modification of the 20S proteasome.
Silva GM; Netto LE; Discola KF; Piassa-Filho GM; Pimenta DC; Bárcena JA; Demasi M
FEBS J; 2008 Jun; 275(11):2942-55. PubMed ID: 18435761
[TBL] [Abstract][Full Text] [Related]
48. Prazosin potentiates the acute hypotensive effects of nitroglycerin but does not attenuate nitrate tolerance in normal conscious rats.
Wang EQ; Fung HL
J Cardiovasc Pharmacol; 2004 Mar; 43(3):341-6. PubMed ID: 15076216
[TBL] [Abstract][Full Text] [Related]
49. The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: Glutathionylation of Rac1 in endothelial cells.
Han J; Weisbrod RM; Shao D; Watanabe Y; Yin X; Bachschmid MM; Seta F; Janssen-Heininger YMW; Matsui R; Zang M; Hamburg NM; Cohen RA
Redox Biol; 2016 Oct; 9():306-319. PubMed ID: 27693992
[TBL] [Abstract][Full Text] [Related]
50. Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner.
Wang J; Pan S; Berk BC
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1283-8. PubMed ID: 17431186
[TBL] [Abstract][Full Text] [Related]
51. Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C.
Zierhut W; Ball HA
Br J Pharmacol; 1996 Sep; 119(1):3-5. PubMed ID: 8872349
[TBL] [Abstract][Full Text] [Related]
52. Rosuvastatin treatment protects against nitrate-induced oxidative stress.
Otto A; Fontaine D; Fontaine J; Berkenboom G
J Cardiovasc Pharmacol; 2005 Aug; 46(2):177-84. PubMed ID: 16044029
[TBL] [Abstract][Full Text] [Related]
53. Two possible mechanisms underlying nitrate tolerance in monkey coronary arteries.
Omura T; Matsumoto T; Nakae I; Takahashi M; Kinoshita M
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):259-65. PubMed ID: 11251637
[TBL] [Abstract][Full Text] [Related]
54. Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and -nontolerant rats.
Csont T; Páli T; Szilvássy Z; Ferdinandy P
Biochem Pharmacol; 1998 Nov; 56(9):1139-44. PubMed ID: 9802323
[TBL] [Abstract][Full Text] [Related]
55. Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2.
Chen YR; Nie SD; Shan W; Jiang DJ; Shi RZ; Zhou Z; Guo R; Zhang Z; Li YJ
Eur J Pharmacol; 2007 Sep; 571(1):44-50. PubMed ID: 17585900
[TBL] [Abstract][Full Text] [Related]
56. Tolerance to nitroglycerin in vascular smooth muscle cells: recovery and cross-tolerance to sodium nitroprusside.
Zhang LM; Castresana MR; Newman WH
Anesth Analg; 1994 Jun; 78(6):1053-9. PubMed ID: 8198258
[TBL] [Abstract][Full Text] [Related]
57. Reduced endothelium-dependent vasodilation by acetylcholine and bradykinin in isolated nitroglycerin-tolerant blood vessels.
Fukazawa M; Namiki A
Gen Pharmacol; 1994 Jan; 25(1):61-7. PubMed ID: 8026713
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms underlying nitrate-induced endothelial dysfunction: insight from experimental and clinical studies.
Warnholtz A; Tsilimingas N; Wendt M; Münzel T
Heart Fail Rev; 2002 Oct; 7(4):335-45. PubMed ID: 12379819
[TBL] [Abstract][Full Text] [Related]
59. Explaining the phenomenon of nitrate tolerance.
Münzel T; Daiber A; Mülsch A
Circ Res; 2005 Sep; 97(7):618-28. PubMed ID: 16195486
[TBL] [Abstract][Full Text] [Related]
60. Nitrate tolerance impairs nitric oxide-mediated vasodilation in vivo.
Laursen JB; Boesgaard S; Poulsen HE; Aldershvile J
Cardiovasc Res; 1996 May; 31(5):814-9. PubMed ID: 8763412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
